AU4356689A - Process for the preparation of 4-o-alkylrhodomycins - Google Patents
Process for the preparation of 4-o-alkylrhodomycinsInfo
- Publication number
- AU4356689A AU4356689A AU43566/89A AU4356689A AU4356689A AU 4356689 A AU4356689 A AU 4356689A AU 43566/89 A AU43566/89 A AU 43566/89A AU 4356689 A AU4356689 A AU 4356689A AU 4356689 A AU4356689 A AU 4356689A
- Authority
- AU
- Australia
- Prior art keywords
- alkyl
- group
- acyl
- protective group
- rhodomycins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
- C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
- C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
- C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
A process for preparing 4-O-alkyl-rhodomycins of the formula I <IMAGE> in which R<1> is H, C1-C4-alkyl or an acyl protective group, R<2> is OH, COOCH3, O-Si(C1-C4-alkyl)3 or an O-acyl protective group, where acyl is acetyl, mono-, di- or trihalogenoacetyl with fluorine or chorine as halogen, benzoyl or p-nitrobenzoyl, R<3> is C1-C4-alkyl, R<4> is H or R<4> and R<5> together are a tetraisopropyldisiloxane-1,3-diyl protective group, R<5> is H or a glycosyl radical of the formula II <IMAGE> in which R<6> is OH, acetyloxy, NHCOCF3, NH2, a mono- or di-C1-C4-alkyl amino group or a 4-morpholinyl group, R<7> is H, OH, an acetyloxy, trifluoroacetyloxy or p-nitrobenzoyloxy group, and the use thereof for preparing 7-O-glucosyl-rhodomycins which, by reason of their cytostatic activity, are suitable for the treatment of cancers, are described.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3836122 | 1988-10-22 | ||
DE3836122A DE3836122A1 (en) | 1988-10-22 | 1988-10-22 | METHOD FOR PRODUCING 4-0-ALKYL RHODOMYCINES |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4356689A true AU4356689A (en) | 1990-04-26 |
Family
ID=6365756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU43566/89A Abandoned AU4356689A (en) | 1988-10-22 | 1989-10-20 | Process for the preparation of 4-o-alkylrhodomycins |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0365973B1 (en) |
JP (1) | JPH02164840A (en) |
KR (1) | KR900006358A (en) |
AT (1) | ATE98626T1 (en) |
AU (1) | AU4356689A (en) |
CA (1) | CA2001087A1 (en) |
DE (2) | DE3836122A1 (en) |
DK (1) | DK523189A (en) |
PT (1) | PT92031B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU633671B2 (en) * | 1989-12-27 | 1993-02-04 | Behringwerke Aktiengesellschaft | Process for the preparation of glycosylanthracyclinones |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT3771013T (en) * | 2018-03-23 | 2023-06-14 | Tomiyama Pure Chemical Industries Ltd | Electrolyte for power storage devices and nonaqueous electrolyte solution |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3641833A1 (en) * | 1986-12-08 | 1988-06-09 | Behringwerke Ag | CYTOSTATICALLY EFFECTIVE ANTHRACYCLINE DERIVATIVES |
DE3641835A1 (en) * | 1986-12-08 | 1988-06-16 | Behringwerke Ag | CYTOSTATICALLY EFFECTIVE ANTHRACYCLINE DERIVATIVES |
DE3712350A1 (en) * | 1987-04-11 | 1988-10-20 | Behringwerke Ag | SEMISYNTHETIC RHODOMYCINES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS CYTOSTATICS |
-
1988
- 1988-10-22 DE DE3836122A patent/DE3836122A1/en not_active Ceased
-
1989
- 1989-10-17 EP EP89119222A patent/EP0365973B1/en not_active Expired - Lifetime
- 1989-10-17 DE DE89119222T patent/DE58906440D1/en not_active Expired - Fee Related
- 1989-10-17 AT AT89119222T patent/ATE98626T1/en not_active IP Right Cessation
- 1989-10-19 PT PT92031A patent/PT92031B/en not_active IP Right Cessation
- 1989-10-20 JP JP1271937A patent/JPH02164840A/en active Pending
- 1989-10-20 AU AU43566/89A patent/AU4356689A/en not_active Abandoned
- 1989-10-20 KR KR1019890015079A patent/KR900006358A/en not_active Application Discontinuation
- 1989-10-20 CA CA002001087A patent/CA2001087A1/en not_active Abandoned
- 1989-10-20 DK DK523189A patent/DK523189A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU633671B2 (en) * | 1989-12-27 | 1993-02-04 | Behringwerke Aktiengesellschaft | Process for the preparation of glycosylanthracyclinones |
Also Published As
Publication number | Publication date |
---|---|
PT92031A (en) | 1990-04-30 |
DE3836122A1 (en) | 1990-05-31 |
EP0365973B1 (en) | 1993-12-15 |
DK523189A (en) | 1990-04-23 |
EP0365973A1 (en) | 1990-05-02 |
CA2001087A1 (en) | 1990-04-22 |
KR900006358A (en) | 1990-05-08 |
JPH02164840A (en) | 1990-06-25 |
DE58906440D1 (en) | 1994-01-27 |
PT92031B (en) | 1995-06-30 |
DK523189D0 (en) | 1989-10-20 |
ATE98626T1 (en) | 1994-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY103388A (en) | Azithromycin and derivatives as antiprotozoal agents | |
HK1008020A1 (en) | Glycosylated prodrugs process for their preparation and uses thereof | |
AU3362984A (en) | Trace-labeled conjugates of metallothionein and target- seeking biologically active molecules | |
GR3006630T3 (en) | ||
AU3119995A (en) | Treatment of cancer using hsv mutant | |
IL100054A0 (en) | 1,3-bis-(3-(mono-or poly-hydroxy)acylamino-5-(mono-or poly-hydroxy-alkyl)aminocarbonyl-2,4,6-triodo-benzoyl-amino)-hydroxy-or hydroxyalkyl-propanes,their methods of preparation and x-ray contrast media containing them | |
ZA894777B (en) | New substituted sulphonamides | |
DE3563533D1 (en) | Derivatives of glycerophosphocholine and of glycerophosphoethanol amine, their preparation and use | |
IE863381L (en) | Antibiotics | |
HU913572D0 (en) | Complexes containing s(+)-phenyl-alkane-acids and amino-sugars | |
AU6578890A (en) | Nonionic x-ray contrast medium with high iodine content | |
AU4356689A (en) | Process for the preparation of 4-o-alkylrhodomycins | |
ZA855224B (en) | Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use | |
ES8707734A1 (en) | Cephalosporins, process for their preparation and their use in medicaments. | |
DE3572441D1 (en) | Use of interferon gamma (ifn-gamma) for the production of preparations for treating rheumatic diseases | |
AU8816682A (en) | 3-phenoxypropan-2-ol derivatives | |
AU8144687A (en) | Peptides | |
EP0292806A3 (en) | Substituted vinyl cephalosporins, process for their preparation and their use as medicines | |
EP0317913A3 (en) | Di(meth)acrylates, process for their preparation and their use | |
EP0459176A3 (en) | Oligophosphates with antiviral activity | |
IT1247900B (en) | Cyclo and poly-phosphazenes containing substituents with ethylenic double bonds and process for their preparation | |
ES2061722T3 (en) | DERIVATIVES OF FENANTRIDINE, PROCEDURE FOR ITS OBTAINING AND AGENTS FOR THE PERFORMANCE OF THE PROCEDURE. | |
DE3372970D1 (en) | 6-alpha-methyl-prednisolone derivatives, their preparation and utilization | |
IT1274010B (en) | Use of mifepristone for the production of endogenous alpha interferon | |
WO1992013072A3 (en) | Process for the synthesis and purification of human ciliary neuronotrophic factor (cntf) from escherichia coli |